Abstract
introductionNeuromodulation has been a treatment for dysfunctional elimination syndromes since 1997. Nevertheless, its applications in the pediatric population appeared 10 years later. Since then, various series have reported on the usefulness of Interstim® therapy in the management of both urinary and gastrointestinal functional disorders. MethodologyThrough a retrospective study, we presented our current experience in the management of different urinary and gastrointestinal functional disorders in children that have not responded to medical treatment and for whom neuromodulation is the only treatment option. ResultsThe Interstim® device was implanted in 9 children within the time frame of 2008 and 2013, with a mean follow-up period of 6 months. The procedure was performed by one urologist. Indications for having the device implantation, failed prior treatments, and the urodynamic behavior of each of the patients were evaluated and interrogations on the impact on quality of life were conducted. The primary aim was to evaluate the improvement of the symptoms that were the motivation for the implantation. DiscussionNeuromodulation in children through sacral root stimulation is a safe and effective procedure when performed on well-selected patients by adequately trained personnel.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
